Pilot Sub-Study of the Effect of Hepatitis C Cure by Glecaprevir/Pibrentasvir on the Gut Microbiome of Patients with Chronic Hepatitis C Genotypes 1 to 6 in the Mythen Study

In this small pilot sub-study, longitudinal gut microbiota composition changes, after successful treatment of hepatitis C virus (HCV) with the co-formulated glecaprevir/pibrentasvir (GLE/PIB), were analyzed before treatment (baseline) and 12 weeks post-treatment. Participating patients provided a fr...

Descripción completa

Detalles Bibliográficos
Autores principales: Yilmaz, Bahtiyar, Ruckstuhl, Lisa, Müllhaupt, Beat, Magenta, Lorenzo, Kuster, Melanie Harrer, Clerc, Olivier, Torgler, Ralph, Semmo, Nasser
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8472424/
https://www.ncbi.nlm.nih.gov/pubmed/34577631
http://dx.doi.org/10.3390/ph14090931

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8472424/
https://www.ncbi.nlm.nih.gov/pubmed/34577631
http://dx.doi.org/10.3390/ph14090931

Ejemplares similares